Bausch Health Companies (NYSE:BHC) jumps 35% premarket on light volume in reaction to a report that it plans to spin of Bausch + Lomb which accounted have its revenue last year.
It acquired the eye care business for $8.7B in 2013 under then-CEO Michael Pearson.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.